Trial To Test Experimental Drug For Advanced Pancreatic Cancer
Cancer Research UK’s Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat. Around 60 patients with advanced pancreatic cancer will be recruited for the first Phase I/IIclinical trial of a drug called MK-0752** in this disease…
Society For Vascular Medicine Features Case Study, Special Section On Peripheral Artery Disease During PAD Awareness Month
One in 20 Americans over age 50 has Peripheral Artery Disease (PAD), a condition that robs them of their independence and mobility by increasing the risk of heart attack, stroke, amputation and death. The Society for Vascular Medicine (SVM) is working to increase awareness of PAD, its diagnosis and treatment…
Frugal Microbes Reduce The Cost Of Proteins
Bacteria tend to be more frugal when constructing proteins for use outside of the cell versus internally, saving their energy for synthesizing compounds that can be recycled, according to research published in the current issue of the online journal mBio™…
Grapefruit’s Bitter Taste Holds A Sweet Promise For Diabetes Therapy
Naringenin, an antioxidant derived from the bitter flavor of grapefruits and other citrus fruits, may cause the liver to break down fat while increasing insulin sensitivity, a process that naturally occurs during long periods of fasting…
ADA 2010 Annual Session Features Latest Products, Technologies In Dentistry
There’s still time to register and gain firsthand knowledge of the latest products, technologies and techniques in dentistry at the American Dental Association’s (ADA) 151st Annual Session and World Marketplace Exhibition. It takes place Oct. 9 - Oct. 12 at the Orlando (Fla.) Orange County Convention Center…
Cancer Center To Be The First In Europe To Install A CyberKnife VSI System, The Latest Generation Of The CyberKnife System
Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center (CLB) in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family…
DASH Eating Plan Lowers Long-Term Heart Attack Risk, Especially Among African-Americans
The DASH eating plan, known to reduce blood pressure and bad cholesterol, also reduces the 10-year risk of heart attack, especially among African-Americans, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal…
Self Care’s Rheumatoid Arthritis Health Campaign Wins Top Award
The Pharmaceutical Society of Australia’s Self Care Program has won Australia’s leading health promotion award for its rheumatoid arthritis campaign. The Australian Journal of Pharmacy Award for the Best Health Promotion of the Year was last night presented to the Self Care campaign…
Optimer Pharmaceuticals Announces Presentations Of Additional Fidaxomicin Phase 3 Data At Upcoming ICAAC Annual Meeting
Results from studies related to Optimer Pharmaceuticals, Inc.’s (Nasdaq: OPTR) lead developmental product candidate, fidaxomicin, will be presented at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) to be held at the Boston Convention and Exhibition Center in Boston on September 12-15, 2010…
New Research: Cranberry Juice Shows Promise Blocking Staph Infections
Expanding their scope of study on the mechanisms of bacterial infection, researchers at Worcester Polytechnic Institute (WPI) have reported the surprise finding from a small clinical study that cranberry juice cocktail blocked a strain of Staphylococcus aureus (S. aureus) from beginning the process of infection…
